Back to Search
NASSER HANNA, MD
MD
Medical Oncology Physician
NPI: 1316903883IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
01050850(IN)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
01050850A(IN)
CMS Specialties
PrimaryMEDICAL ONCOLOGY
Education
OTHER
Class of 1995
Research & Publications (20)
Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology.
PMID 19001323·J Clin Oncol·2008
3-trial
A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study.
PMID 17375339·Support Care Cancer·2007
3-trial
Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer.
PMID 17114658·J Clin Oncol·2006
3-trial
Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.
PMID 16648503·J Clin Oncol·2006
3-trial
Advances in the treatment of second-line non-small-cell lung cancer.
PMID 16291425·Lung Cancer·2005
4-observational
Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy.
PMID 15117980·J Clin Oncol·2004
3-trial
Second-line chemotherapy for non-small-cell lung cancer: recent data with pemetrexed.
PMID 15117429·Clin Lung Cancer·2004
6-review
Phase I trial of carboplatin and paclitaxel with escalating doses of oral topotecan in patients with solid tumors.
PMID 12714897·Am J Clin Oncol·2003
3-trial
Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study.
PMID 11863118·Ann Oncol·2002
3-trial
A retrospective analysis comparing patients 70 years or older to patients younger than 70 years with non-small-cell lung cancer treated with surgery at Indiana university: 1989-1999.
PMID 14662043·Clin Lung Cancer·2002
8-other
The value of platinum compounds in non-small-cell lung cancer.
PMID 14662032·Clin Lung Cancer·2002
8-other
Phase I trial of topotecan plus vinorelbine with/without filgrastim (G-CSF) in patients with refractory malignancies.
PMID 12151959·Am J Clin Oncol·2002
3-trial
Primary choriocarcinoma of the bladder with the detection of isochromosome 12p.
PMID 11912411·J Urol·2002
5-case
Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): a Hoosier Oncology Group (HOG) phase II study.
PMID 11844604·Lung Cancer·2002
3-trial
High-dose carboplatin with etoposide in patients with recurrent thymoma: the Indiana University experience.
PMID 11593315·Bone Marrow Transplant·2001
3-trial
SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome.
PMID 19438935·Clin Genet·2009
5-case
Feasibility of three-dimensional optical coherence tomography and optical Doppler tomography of malignancy in hamster cheek pouches.
PMID 16875451·Photomed Laser Surg·2006
7-preclinical
Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: consequences for PI3K binding on Gab1.
PMID 16638574·FEBS Lett·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 535 BARNHILL DR, RT 473
INDIANAPOLIS, IN 46202 - Phone
- (317) 278-0054
Quick Facts
- NPI
- 1316903883
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile